Watch on-demand! Belmar Pharma Solutions’ Preferred Provider webinar: “Testosterone on Trial: The Metabolic Truth Behind Men’s Health”
Learn directly from hormone expert and Belmar Pharma Solutions Medical Director, Angela DeRosa, DO, MBA, CPE, plus special guest, Ilya Rabkin, MD, MBA, FAAFP, Founder Concierge & Longevity Physician of ZinovyMed. Rachel Noonan, PharmD, Belmar’s Clinical Research and Content Marketing Pharmacist, is also joining the panel.
Dr. DeRosa and Dr. Rabkin present the research and candidly discuss:
- How cardiovascular risk became a concern and led to the addition of the Black Box warning on male testosterone products.
- The association of testosterone therapy with mortality/myocardial infarction and stroke in men with low testosterone levels.
- A brief review of studies that show positive cardiovascular/metabolic risk effects from testosterone therapy (contrary to published articles).
- The cardiovascular safety of testosterone replacement therapy (TRT).
- Traverse Trial: Cardiovascular safety of testosterone therapy for older men.
- The Androgen Society Position Paper on cardiovascular risk with testosterone therapy.
Watch on-demand today.
This webinar is intended for providers. If you are a provider and would like to watch the webinar, please fill out the form below.
